Carly Crapanzano
Optometrist · Iselin, NJNPI 1568682920
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Lumenis BE Inc at 38.2% of the total. 2025 is the largest year on record at $3,973, more than ten times the $274 reported in 2019. Among optometrist clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 85 payments — averaging $74.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lumenis BE Inc$2K
- AbbVie$1K
- Johnson & Johnson Surgical Vision, Inc.$1K
- Alcon$202
- Sanofi$191
- Glaukos Corporation$186
- plus $1K from 17 others
What the payments were for
- Food & beverage$6,354100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lumenis BE Inc | 1 | $2,429 |
| AbbVie(2 entities) | 43 | $1,286 |
| Johnson & Johnson Surgical Vision, Inc. | 13 | $1,033 |
| Alcon | 2 | $202 |
| Sanofi | 2 | $191 |
| Glaukos Corporation | 1 | $186 |
| Rxsight Inc | 1 | $144 |
| NEW World Medical,inc. | 1 | $125 |
| Harrow Eye, LLC | 2 | $118 |
| Aerie Pharmaceuticals, Inc. | 1 | $105 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $100 |
| Novartis | 1 | $93 |
| Tarsus Pharmaceuticals, Inc. | 4 | $74 |
| Sight Sciences, Inc. | 1 | $58 |
| Thea Pharma Inc. | 2 | $36 |
| Mallinckrodt Hospital Products Inc. | 2 | $35 |
| Coopervision Inc. | 1 | $28 |
| Visioneering Technologies, Inc. | 1 | $26 |
| Apellis Pharmaceuticals, Inc. | 1 | $19 |
| Oyster Point Pharma, Inc. | 1 | $18 |
| Sun Pharmaceutical Industries Inc. | 1 | $18 |
| Rayner Intraocular Lenses Limited | 1 | $16 |
| Bausch & Lomb Americas Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,354 in reported general payments places this provider in the 95th percentile of 1,357 optometrist providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Timolol Maleate | 28 | $1,430 |
| Latanoprost | 51 | $355 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 12 | $142 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Iselin
- Melanne RosettaIselin$66K
- Eric DevoreIselin$17K
- Muhammad ShahbakhtIselin$13K
- Natalie NguyenIselin$10K
- Michael VelikyIselin$6K
- Frances TsaiIselin$6K
- Kerry GelbWoodbridge$264K
- Rodolfo RodriguezNorth Bergen$244K
- Steven SorkinFairfield$146K
- Paul VaccarellaRockaway$99K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.